Articles tagged with Hepatocellular Carcinoma
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A study found that S-adenosylmethionine (SAMe) prevents the formation of hepatocellular carcinoma (HCC) in rats, with a 1cm tumor reduced in size after treatment. However, high doses were not sufficient to treat established HCC cases, as the liver compensates for SAMe accumulation by metabolizing it.
Studies reveal that hepatitis C virus carriers have a significant increase in mortality, with liver-related deaths being the leading cause. The research found that monitoring HCV load and ALT levels may be crucial for identifying high-risk individuals, particularly older carriers who are less responsive to treatment.
A large meta-analysis found certain HBV DNA mutations associated with HCC development and more prevalent in chronic HBV infection progression. The study may help predict liver cancer risk in patients with HBV infections.
A DNA vector-based approach silences STAT3, inhibiting HCC cell growth and inducing apoptosis. This study demonstrates RNAi's therapeutic potential in treating HCC by targeting the STAT3 gene.
The presence of multiple portal vein invasion (PVI) is a significantly poor prognostic factor for hepatocellular carcinoma. Anatomical resection is recommended for patients with HCC and PVI-M, while non-anatomical resection may lead to poorer disease-free survival.
Researchers evaluated percutaneous radiofrequency ablation (PAA) as an alternative to conventional RFA in treating hypervascular HCC. The study found that PAA significantly reduced post-RFA recurrence and improved treatment outcomes, making it a promising new approach for this patient population.
Researchers found that a high-fat diet increases the risk of liver cancer in genetically susceptible mice, while switching to a low-fat diet reverses this outcome. The study could lead to screening methods for precancerous conditions and cancer prevention strategies related to obesity.
A study published in the World Journal of Gastroenterology found that type 2 diabetes mellitus is an independent risk factor for hepatocellular carcinoma. The research revealed a direct association between HCC and insulin/sulphanylureas treatment, as well as an inverse relationship with metformin therapy.
Two studies published in Gastroenterology found that statin use is associated with a significant reduction in the risk of hepatocellular carcinoma (HCC) among patients with diabetes. Additionally, statins appear to reduce the risk of cholecystectomy, surgical removal of the gallbladder, in women.
A new study published in Hepatology found that women with a history of hypothyroidism are at a significantly higher risk of developing liver cancer. The study revealed that subjects with a prior history of hypothyroidism had twice the risk of liver cancer, particularly for females, and those who had it for over 10 years had a threefold...
A new study shows radioembolisation to be a safe and effective treatment for patients with advanced HCC, achieving partial response rates of up to 80% and comparable survival rates to systemic therapy. The technique may offer a novel palliative therapeutic approach for those with limited options.
Researchers found that combining vitamin K with sorafenib reduced the need for higher doses of sorafenib by more than 50% in both pancreas cancer and hepatocellular carcinoma studies. This combination also inhibited tumor growth and induced cell death, offering a potential cure strategy.
A prospective cohort study found TACE treatments to be well-tolerated and safe for asymptomatic patients with preserved liver function, with a high HCC progression-free survival probability. The study's results support the efficacy of selective TACE in prolonging life expectancy and confirm its role as a key treatment option.
A rare case of liver cell adenoma (LCA) was reported in a woman without typical background, showing sequential alteration in radiological findings suggesting well-differentiated HCC. The patient underwent partial hepatectomy and pathological findings confirmed the diagnosis of LCA.
Research identifies GABRA3 subunit overexpression in hepatocellular carcinoma (HCC) cells, promoting cell growth and proliferation. The study suggests that targeting the GABAergic system may be a promising approach for HCC diagnosis and treatment.
Researchers at Virginia Commonwealth University identified a gene, AEG-1, that plays a key role in regulating liver cancer progression. The study found that AEG-1 expression increases as the tumor becomes more aggressive and is involved in invasion, metastasis, resistance to chemotherapy, and other processes.
Researchers have identified a gene AEG1 that plays a key role in human liver cancer progression. Targeting this gene may provide new therapeutic options for treating liver cancer. Additionally, adenosine signaling has been linked to alcohol-induced fatty liver disease in mice, suggesting potential treatments involving adenosine receptors.
Researchers identified AEG1 as a gene and protein crucial for HCC progression, suggesting targeting it may be a new therapeutic strategy. Overexpression of AEG1 accelerated tumor growth in mouse models.
A new study identifies Capn4 as a key molecule associated with liver cancer recurrence and metastasis after liver transplantation. The findings suggest that Capn4 expression is correlated with clinical outcomes and could be used as a prognostic marker for diagnosis.
A study found that HCC cases with AIH and PBC have four clinical features: shorter survival intervals, more men affected, and liver failure as primary cause of death. The research highlights these common characteristics in HCC associated with AIH and PBC.
A phase III trial found sorafenib to be effective in increasing overall survival by 6.5 months compared to 4.2 months in the placebo group, and prolonged time to progression and disease control rate. Sorafenib was generally well-tolerated with some side effects.
A new set of criteria, called Up-to-seven, has been identified to help select patients with hepatocellular carcinoma (HCC) who can benefit from liver transplantation. The criteria assess the size and number of tumors, and suggest that some patients who previously did not meet the Milan criteria may still be good candidates for transplant.
Researchers have developed approaches to visualize eosinophils in real-time, which may help diagnose asthma and assess treatment efficacy. Additionally, genetic defects underlying two kidney conditions and a type of liver cancer have been identified, suggesting potential therapeutic targets for these diseases.
This study investigates the correlation between changes in CT perfusion parameters pre- and post-TACE treatment of HCC and various responses to TACE. The findings suggest that CT perfusion imaging is a feasible technique for monitoring response of HCC to TACE, indicating its potential as an adjunctive tool in clinical practice.
A large population-based case-control study found that patients with type 2 diabetes mellitus (DM2) have a significantly increased risk of hepatocellular carcinoma (HCC), independent of cofactors. The study suggests that DM2 may be a concourse rather than merely a consequence of the liver tumor.
Researchers found MRN can be differentiated from HCC using CT/MRI features, including typical hyperdense appearance and lack of enhancement. Liver biopsy can be avoided if supported by these images, reducing the need for repeated biopsies.
A previously asymptomatic man developed a huge peritoneal mass after spontaneous rupture of hepatocellular carcinoma. The association between the metastatic tumor and viral infection, AFP level, or age was lacking due to few reported cases.
A new therapeutic option for human hepatocyte cancer has been identified, leveraging parvovirus H-1 oncolytic therapy. The treatment targets p53-deficient tumors and induces apoptosis, potentially overcoming resistance to genotoxic agents.
A study published in World Journal of Gastroenterology found high circulating D-dimer levels associated with ascites presence in liver cirrhosis patients. Ascites depletion may prevent bleeding complications. High D-dimer levels also linked to hepatocellular carcinoma (HCC) in cirrhotic patients without ascites.
A randomized controlled trial found that combining TACE and RFA therapies resulted in longer survival times for patients with large liver cancer tumors. The therapy improved survival by slowing tumor progression and blocking the blood supply to the tumor.
Research found prokineticin 2/Bv8 is downregulated in human hepatocellular carcinoma, but expressed in liver resident macrophages, suggesting a role in Kupffer cell physiology.
A study published in the World Journal of Gastroenterology found that Fu-Zheng-Jie-Du-Decoction increased PTEN expression in hepatocellular carcinoma, suggesting a promising future for TCM as a combined therapy. The decoction was shown to decrease tumor metastasis and improve survival rates compared to chemotherapy.
Researchers found that Gas6 protein increases cell signaling in response to Epo treatment and treats both chronic and acute anemia in mice. Additionally, mice deficient in Gas6 have decreased sensitivity to Epo and reduced ability to recover from anemia.
A specific gene variation appears to significantly increase the risk of developing hepatocellular carcinoma (HCC) in patients with cirrhosis. Researchers found that elevated EGF levels and activation of the EGFR receptor were associated with a higher risk of HCC in patients with at least one copy of the G allele.
A study found massive necrosis after trans-catheter treatment for liver cancer to be more common when a tumor capsule is present. Patients with tumors between 2-6 cm, low CLIP scores, and no constitutional syndrome were most likely to experience this outcome.
A 24-week course of interferon-alpha therapy after curative treatment for HCV-associated HCC significantly reduces tumor recurrence rates and improves patient survival compared to those without interferon therapy. Patients who achieved a sustained virological response also exhibit improved liver function and prolonged overall survival.
A new potential therapeutic target for early-stage hepatocellular carcinoma has been identified through a study published in the World Journal of Gastroenterology. Survivin protein expression was found to be elevated in 64.7% of HCC specimens, suggesting its role as a marker for diagnosis and treatment.
Researchers examined the effectiveness of intra-arterial combination chemotherapy in treating advanced hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT). The treatment led to a median survival time of 457.2 days and a one-year survival rate of 70%.
A Chinese medicine compound, delisheng, has shown satisfactory anti-cancer effects on hepatocellular carcinoma cells in a three-dimensional cell culture model. The compound's ginseng component is believed to be responsible for its anti-tumor activity, which may lead to new treatment options for HCC patients.
Researchers discovered that nerve growth factor (NGF) is positively related with liver cancer, the No.2 killer among all kinds of cancers. NGF and its receptor trkANGF were expressed in liver cells of patients with liver cirrhosis and/or hepatocellular carcinoma.
Researchers have developed a new blood screening technique that can detect early-stage liver cancer and predict treatment outcomes. They detected an altered version of RASSF1A, a tumor-suppressing gene, in the blood of HCC patients and HBV-infected test subjects, with promising results.
Researchers discovered that nerve growth factor (NGF) is positively related to liver cancer and may be expressed by liver cells to affect themselves or adjacent cells. Targeting NGF could suppress or prevent the development of liver cirrhosis and hepatocellular carcinoma.
Researchers developed a new blood test to detect liver cancer in an early stage, improving detection accuracy by 70%. The test uses the ratio of two sugar groups on blood proteins to identify liver cancer in patients with cirrhosis.
A meta-analysis of 11 studies on coffee consumption and hepatocellular carcinoma (HCC) found a 41% reduction in HCC risk among coffee drinkers. The study suggests that compounds in coffee may act as blocking agents, reducing carcinogenic detoxification and liver disease risk.
Research at University of California, San Diego reveals that male mice produce more IL-6 in response to liver injury, leading to a higher incidence of liver cancer. The study suggests therapies targeting IL-6 production or estrogen-like compounds may reduce liver cancer risk in males.
The Sorafenib HCC Assessment Randomized Protocol (SHARP) Trial demonstrated Nexavar's effectiveness in extending overall survival by 44% compared to placebo. Hepatocellular carcinoma is the most common form of liver cancer, responsible for about 90% of primary malignant liver tumors in adults.
Patients with liver cancer undergoing chemotherapy who have high serum levels of hepatitis B virus (HBV) DNA are at risk of developing severe hepatitis, which is associated with poor survival. Researchers found that a pre-chemotherapy HBV viral load above 10^5.65 copies per milliliter was linked to poorer outcomes.
Researchers at Columbia University's Mailman School of Public Health discovered a means for early detection of liver cancer using DNA isolated from serum samples. The study found changes associated with cancer in serum DNA one to nine years before actual clinical diagnosis, leading to an overall predictive accuracy of 89%.
The study found that survival rates for patients with hepatitis B who need liver transplants are similar between those with and without hepatocellular carcinoma (HCC). Despite the higher likelihood of transplantation, 5-year survival rates were comparable between the two groups. The findings suggest that antiviral therapy may have bene...
A recent double-blind study found that long-acting octreotide did not improve outcomes for patients with liver cancer compared to a placebo. The study enrolled 119 patients and followed them for over 30 months, but showed no significant difference in survival rates between the two groups.
A study found that higher levels of specialized blood cells from bone marrow are associated with liver cancer prognosis. Elevated endothelial progenitor cells were linked to poorer outcomes in patients with inoperable hepatocellular carcinoma.
A recent study found that colchicine significantly reduces the risk of developing hepatocellular carcinoma (HCC) in patients with hepatitis virus-related end-stage liver disease. Colchicine treatment delays HCC diagnosis by an average of 72 months and improves survival rates.
A new study found that liver cancer metastasis is influenced by the local tissue's microenvironment, with a unique gene expression signature predicting metastatic potential. The researchers identified a key role for colony-stimulating factor 1 in promoting anti-inflammatory conditions supporting tumor growth and metastasis.
Researchers found that patients with hepatocellular carcinoma who responded well to transarterial chemoembolization (TACE) prior to liver transplantation had a higher survival rate. The study's findings challenge the traditional use of Milan criteria, which rely on tumor size and number, as a reliable predictor of recurrence.
Researchers identified 254 gene sequences in melanomas that may inhibit metastasis and found high retinol levels reduce risk of hepatocellular carcinoma. Grb7 peptide inhibitor targets pancreatic cancer cells, showing promise as a new therapy.
Researchers have found that combining the monoclonal antibody C225 with photodynamic therapy in a mouse model of ovarian cancer resulted in substantial tumor reduction and improved survival rates compared to single-agent treatments. This innovative approach may provide new hope for women diagnosed with this aggressive form of cancer.
Scientists have found that the hepatitis B virus primes liver cells to turn cancerous by 'turning off' an enzyme called GSK-3ß, which normally suppresses tumor formation. This discovery has potential relevance for other cancers and could lead to novel therapeutic approaches, including gene therapy and small molecules.
Studies show that smoking, red meat intake, and alcohol use increase the risk of serious gastrointestinal cancers. Patients who used tobacco and/or alcohol were diagnosed three to five years earlier on average than those who never smoked or drank.
A nested case-control study found that higher HBV viral loads were associated with increased liver cancer risk in Taiwanese men. Genotype C was also linked to a five-fold increased risk of HCC, with effects exacerbated by high viral load levels.
A study has identified two distinct subclasses of liver cancer with differing survival rates, providing new molecular insight into the pathogenesis of hepatocellular carcinoma. The findings suggest that gene expression profiles can accurately predict patient survival and may lead to the development of more targeted therapies.